PSP Research »

Amylyx Pharmaceuticals shares owned by PSP Research

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by PSP Research

Quarter filed Position value Share count Share price at filing
2025-12-31 $534k 44k 12.08

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Praxis Precision Medicines I Com New (PRAX)
Travere Therapeutics (TVTX)
Tyra Biosciences (TYRA)
Pharvaris N V (PHVS)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Celldex Therapeutics Com New (CLDX)
Cg Oncology (CGON)
Belite Bio Sponsored Ads (BLTE)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apellis Pharmaceuticals (APLS)
Terns Pharmaceuticals (TERN)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)

View all positions for PSP Research

Top funds holding Amylyx Pharmaceuticals

FMR
BlackRock
Perceptive Advisors
Adage Capital Partners GP
TCG Crossover Management
Vanguard Group
Commodore Capital
Saturn V Capital Management
First Light Asset Management
Goldman Sachs Group
Henderson Group
Driehaus Capital Management
Geode Capital Management
Almitas Capital
State Street Corporation

View all funds holding Amylyx Pharmaceuticals